Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors.
paper
Cited
Public
Unavailable
- Authors
- Glick, Stanley D; Maisonneuve, Isabelle M; Kitchen, Barbara A
- Year
- 2002
- Journal
- European journal of pharmacology
- PMID
- 12144940
- DOI
- 10.1016/s0014-2999(02)01944-1
18-Methoxycoronaridine, a novel iboga alkaloid congener that decreases drug self-administration in several animal models, may be a potential treatment for multiple forms of drug abuse. In previous work, 18-methoxycoronaridine was found to be a somewhat selective antagonist at alpha3beta4 nicotinic receptors; and low dose combinations of 18-methoxycoronaridine with other drugs known to have the same action (e.g., mecamylamine, dextromethorphan) decreased both morphine and methamphetamine self-administration in rats at doses that were ineffective if administered alone. In the present study, similar drug combinations (but including bupropion as well) were found to decrease nicotine self-administration in rats. The data further support the hypothesis that diencephalic pathways having high densities of alpha3beta4 nicotinic receptors modulate mesocorticolimbic pathways more directly involved in drug reinforcement. Antagonists of alpha3beta4 nicotinic receptors may represent a totally novel approach to treating polydrug abuse.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking. | 2012 | 22438940 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Elucidating the reinforcing effects of nicotine: a tribute to Nadia Chaudhri. | Sved AF et al. | β | 2023 | β |
| (-)-Adaline from the <i>Adalia</i> Genus of Ladybirds Is a Potent Antagonist of Insect and Specific Mammalian Nicotinic Acetylcholine Receptors. | Richards DP et al. | β | 2022 | β |
| Synthesis and evaluation of disulfide-rich cyclic Ξ±-conotoxin [S9A]TxID analogues as novel Ξ±3Ξ²4 nAChR antagonists. | Wang S et al. | β | 2021 | β |
| Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats. | Blair G et al. | β | 2020 | β |
| Chronic memantine decreases nicotine self-administration in rats. | Levin ED et al. | β | 2019 | β |
| Mutagenesis of Ξ±-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors. | Turner MW et al. | β | 2019 | β |
| Selectivity of (Β±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular Ξ±3Ξ²4* and Ξ±9Ξ±10 subtypes. | Arias HR et al. | β | 2019 | β |
| Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys. | Withey SL et al. | β | 2018 | β |
| Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats. | Levin ED et al. | β | 2018 | β |
| The wonderland of neuronal nicotinic acetylcholine receptors. | Bertrand D et al. | β | 2018 | β |
| Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula. | Arias HR et al. | β | 2017 | β |
| Coronaridine congeners inhibit human Ξ±3Ξ²4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. | Arias HR et al. | β | 2015 | β |
| Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats. | Malcolm E et al. | β | 2015 | β |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | β | 2015 | β |
| [ΒΉΒ²β΅I]AT-1012, a new high affinity radioligand for the Ξ±3Ξ²4 nicotinic acetylcholine receptors. | Wu J et al. | β | 2014 | β |
| Bupropion and bupropion analogs as treatments for CNS disorders. | Carroll FI et al. | β | 2014 | β |
| Discovery of a potent and selective Ξ±3Ξ²4 nicotinic acetylcholine receptor antagonist from an Ξ±-conotoxin synthetic combinatorial library. | Chang YP et al. | β | 2014 | β |
| Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats. | Guy EG et al. | β | 2014 | β |
| Effect of Iboga alkaloids on Β΅-opioid receptor-coupled G protein activation. | Antonio T et al. | β | 2013 | β |
| Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse. | Grabus SD et al. | β | 2012 | β |
| Fatalities temporally associated with the ingestion of ibogaine. | Alper KR et al. | β | 2012 | β |
| Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by Ξ±3Ξ²4Ξ±5 nicotinic acetylcholine receptors. | TammimΓ€ki A et al. | β | 2012 | β |
| Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking. | Kapoor M et al. | β | 2012 | β |
| An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine. | Murray JE et al. | β | 2011 | β |
| Brain regions mediating Ξ±3Ξ²4 nicotinic antagonist effects of 18-MC on nicotine self-administration. | Glick SD et al. | β | 2011 | β |
| Improving the stability of Ξ±-conotoxin AuIB through N-to-C cyclization: the effect of linker length on stability and activity at nicotinic acetylcholine receptors. | Armishaw CJ et al. | β | 2011 | β |
| Partial agonists of the Ξ±3Ξ²4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. | Chatterjee S et al. | β | 2011 | β |
| Interactions between morphine, scopolamine and nicotine: schedule-controlled responding in rats. | Li X et al. | β | 2010 | β |
| Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. | Chatterjee S et al. | β | 2010 | β |
| Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration. | Carnicella S et al. | β | 2010 | β |
| Novel Ξ±3Ξ²4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation. | Zaveri N et al. | β | 2010 | β |
| Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights. | Paterson NE | β | 2009 | β |
| Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice. | Biala G et al. | β | 2009 | β |
| Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. | Strong DR et al. | β | 2009 | β |
| Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? | Arias HR | β | 2009 | β |
| Mammalian nicotinic acetylcholine receptors: from structure to function. | Albuquerque EX et al. | β | 2009 | β |
| Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine. | Struthers AM et al. | β | 2009 | β |
| Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement. | Coen KM et al. | β | 2009 | β |
| Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion. | Arias HR et al. | β | 2009 | β |
| The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine. | Paterson NE | β | 2009 | β |
| Bupropion differentially alters the aversive, locomotor and rewarding properties of nicotine in CD-1 mice. | Rauhut AS et al. | β | 2008 | β |
| Bupropion improves attention but does not affect impulsive behavior in healthy young adults. | Acheson A et al. | β | 2008 | β |
| Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal. | De Biasi M et al. | β | 2008 | β |
| Nicotine analog inhibition of nicotine self-administration in rats. | Rowland NE et al. | β | 2008 | β |
| Nicotine and methamphetamine share discriminative stimulus effects. | Gatch MB et al. | β | 2008 | β |
| The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. | Paterson NE et al. | β | 2008 | β |
| The ibogaine medical subculture. | Alper KR et al. | β | 2008 | β |
| Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. | Portugal GS et al. | β | 2007 | β |
| Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. | Paterson NE et al. | β | 2007 | β |
| Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. | Wing VC et al. | β | 2007 | β |
| Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. | Liu X et al. | β | 2007 | β |
| Post-treatment of dextromethorphan reverses morphine effect on conditioned place preference in rats. | Lue WM et al. | β | 2007 | β |
| Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats. | Liu X et al. | β | 2007 | β |
| Translational research in medication development for nicotine dependence. | Lerman C et al. | β | 2007 | β |
| 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats. | Glick SD et al. | β | 2006 | β |
| Bupropion attenuates nicotine abstinence syndrome in the rat. | Malin DH et al. | β | 2006 | β |
| Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats. | Wright MJ et al. | β | 2006 | β |
| Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. | McCallum SE et al. | β | 2006 | β |
| Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. | Liu X et al. | β | 2006 | β |
| Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. | Dwoskin LP et al. | β | 2006 | β |
| Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine. | Panchal V et al. | β | 2005 | β |
| Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats. | Zakharova ES et al. | β | 2005 | β |
| Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion. | Alkondon M et al. | β | 2005 | β |
| Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. | Rauhut AS et al. | β | 2005 | β |
| Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. | Pace CJ et al. | β | 2004 | β |
| Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. | Maisonneuve IM et al. | β | 2003 | β |
| Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. | Bruijnzeel AW et al. | β | 2003 | β |
| Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. | Huang EY et al. | β | 2003 | β |
| Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. | Cryan JF et al. | β | 2003 | β |
| Novel therapies for the treatment of inflammatory airway disease. | Hele DJ et al. | β | 2003 | β |